跳至主要内容
临床试验/NCT02674737
NCT02674737Unknown不适用

Evaluation of the Effect of Appropriate Sedation for Patients After Gastrectomy: A Prospective Randomised Controlled Study

Chinese Medical Association1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2016年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
80
试验地点
1
主要终点
white blood cell count (10^9/L)

研究概览

简要总结

To evaluate the efficacy and safety of appropriate postoperative sedation with dexmedetomidine for patients after gastrectomy. Prospective randomised controlled study was conducted from October 2015 and December 2015 among patients after gastrectomy. The investigators are going to enroll patients who received abdominal surgeries. One group receive sedative along with analgesic and the other group analgesic only for the other group on the first 24 hours after surgeries and follow up for 3 days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-85 years old
  • underwent gastrectomy in the hospital and operation duration lasted at least 2 hours

排除标准

  • take part in other clinical trials
  • quinolone antibiotics intake 4 weeks prior to or within the study
  • NSAIDS intake within one month
  • history of peptic ulcer
  • respiratory insufficiency
  • renal insufficiency
  • acute hepatitis or severe liver disease (Child-Pugh class C)
  • pregnancy or lactation
  • abnormal ECG with clinical significance
  • uncontrolled hypotension
  • bleeding tendency or hematological diseases
  • untreated mechanical intestinal obstruction
  • unable to express or any kind of mental disease.

研究组 & 干预措施

Tramadol and flurbiprofen

Active Comparator

Only routine analgesic(tramadol and flurbiprofen) are applied to this group of patients.

干预措施: tramadol and flurbiprofen (Drug)

Dexmedetomidine,tramadol and flurbiprofen

Experimental

Both sedative and analgesic(dexmedetomidine, tramadol and flurbiprofen) are applied to this group of patients.

干预措施: dexmedetomidine, tramadol and flurbiprofen (Drug)

结局指标

主要结局

white blood cell count (10^9/L)

时间窗: 1-3d after gastrectomy

evaluate postoperative inflammatory response, blood sample collected at 6:00am for 1-3d after gastrectomy

postoperative pain assessed by Prince Henry Pain Scale

时间窗: 1-3d after gastrectomy

assessed by Prince Henry Pain Scale by investigators at 8:00 am after surgeries until discharge from ICU

recovery of gastrointestinal function assessed by time to first defecation after surgery

时间窗: 30 days after gastrectomy

assessed by time to first defecation after surgery

C-reactive protein (mg/L)

时间窗: 1-3d after gastrectomy

evaluate postoperative inflammatory response, blood sample collected at 6:00am for 1-3d after gastrectomy

次要结局

  • percentage of time within target sedation range(1-3d after gastrectomy)
  • risk of bradycardia requiring interventions(1-3d after gastrectomy)
  • risk of hypotension requiring interventions(1-3d after gastrectomy)
  • use of opioids and use of benzodiazepins(1-3d after gastrectomy)

研究者

申办方类型
Network
责任方
Principal Investigator
主要研究者

Juanhong Shen

Director, PhD, Principal Investigator, Resident Physician

Chinese Medical Association

研究点 (1)

Loading locations...

相似试验

Evaluation of the Effect of Appropriate Sedation for... | 临床试验